systemic juvenile idiopathic arthritis
FDA Approves Biogen’s Biosimilar, Challenging Roche’s Actemra Dominance in the Market
Anika Sharma
Biogen has achieved a remarkable milestone while contemplating the future of its biosimilars division. The company proudly announced that its ...
